-
439Wire Stories“Experience the Luxury of Japanese Tradition and Cuisine” Reservations for the New Inbound Experience Tour in Osaka’s Tondabayashi Begin on June 1, 2024!
OSAKA, Japan–(BUSINESS WIRE)–The city of Tondabayashi in Osaka is excited to announce a new inbound tour by “SABIWabisabi,” aimed at revitalizing the...
-
463Wire StoriesTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
− Four-year Analysis Conducted by GHSG Reported ADCETRIS + ECADD Combination Improved Progression-Free Survival, Showing Superior Efficacy and Tolerable Safety Profile in...
-
463Wire StoriesAccutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
– Differentiated Mechanism of Action of a Chimeric Degrader as Compared to Fulvestrant and Novel SERDs – – Treatment with AC699 Monotherapy...
-
4.2KFashionCrafting Timeless Elegance: Unique Ring Designs
Welcome to our in-depth exploration of timeless elegance in unique ring designs. Whether you are a jewelry enthusiast or an engaged couple...
-
576Wire StoriesThe World’s Light Painting Masters and GAC Work Together to Create a Chinese Giant Light-Painted Dragon That Shines in Dubai for the First Time
GUANGZHOU, China–(BUSINESS WIRE)–Coinciding with the Chinese Year of the Dragon in 2024, in order to celebrate the 40th anniversary of the establish...
-
438Wire StoriesGeneration Mining Files Final Base Shelf Prospectus and Updates Shareholders
TORONTO–(BUSINESS WIRE)–Generation Mining Limited (TSX:GENM, OTCQB: GENMF) (“Gen Mining” or the “Company”) is pleased to announce that it has filed a final...
-
414NewsM1 Launches ‘iPhone On Us’ Campaign: Swap Your iPhone at No Cost
M1, Singapore’s premier telecommunications provider, is excited to launch a remarkable campaign that makes the latest mobile technology more affordable for customers...
-
409Wire StoriesIvonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy
Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46 For Subset of...
-
535Wire StoriesCapstone Copper Announces Retirement of Robert Gallagher from the Board of Directors
VANCOUVER, British Columbia–(BUSINESS WIRE)–Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announces that Mr. Robert (“Bob”) Gallagher has retired from the...
-
636Wire StoriesAdani Ports Signs 30-Year Concession to Operate Container Terminal 2 at Dar es Salaam Port
Editor’s Synopsis Concession marks entry of Adani Ports into Tanzania CT2 has a capacity of 1 million TEUs and handles ~83% of...
